CMS will pay 340B hospitals at average sales price plus 6 percent — rather than average sales price minus 22.5 percent — for all calendar year 2022 drug claims with modifier “JG,” the American Hospital Association said Oct. 20.
Read the full post on Becker's Hospital Review - Healthcare News
